These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8548363)

  • 1. Metalloprotease inhibitors halt collagen breakdown in IL-1 induced bovine nasal cartilage cultures.
    Spirito S; Doughty J; O'Byrne E; Ganu V; Goldberg RL
    Inflamm Res; 1995 Aug; 44 Suppl 2():S131-2. PubMed ID: 8548363
    [No Abstract]   [Full Text] [Related]  

  • 2. Matrix metalloproteinase inhibitor CGS 27023A protects COMP and proteoglycan in the bovine articular cartilage but not the release of their fragments from cartilage after prolonged stimulation in vitro with IL-1 alpha.
    Ganu V; Melton R; Wang W; Roberts D
    Ann N Y Acad Sci; 1999 Jun; 878():607-11. PubMed ID: 10415786
    [No Abstract]   [Full Text] [Related]  

  • 3. Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture.
    Cawston TE; Ellis AJ; Humm G; Lean E; Ward D; Curry V
    Biochem Biophys Res Commun; 1995 Oct; 215(1):377-85. PubMed ID: 7575616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures.
    Xu C; Oyajobi BO; Frazer A; Kozaci LD; Russell RG; Hollander AP
    Endocrinology; 1996 Aug; 137(8):3557-65. PubMed ID: 8754787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological evaluation of matrix metalloproteinase inhibitors, 18 May 1995, New York.
    Pratta MA
    Inflamm Res; 1995 Nov; 44(11):458-60. PubMed ID: 8597877
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of the hydroxamic acid derivate Ro 31-4724 on the metabolism and morphology of interleukin-1-treated cartilage explants.
    Steinmeyer J; Daufeldt S; Kalbhen DA
    Pharmacology; 1997 Aug; 55(2):95-108. PubMed ID: 9323309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromelysin 1, neutrophil collagenase, and collagenase 3 do not play major roles in a model of chondrocyte mediated cartilage breakdown.
    Kozaci LD; Brown CJ; Adcocks C; Galloway A; Hollander AP; Buttle DJ
    Mol Pathol; 1998 Oct; 51(5):282-6. PubMed ID: 10193524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine inhibitors of the MMPs and TACE.
    Nelson FC; Delos Santos E; Levin JI; Chen JM; Skotnicki JS; DiJoseph JF; Sharr MA; Sung A; Killar LM; Cowling R; Jin G; Roth CE; Albright JD
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2867-70. PubMed ID: 12270165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures.
    Kozaci LD; Buttle DJ; Hollander AP
    Arthritis Rheum; 1997 Jan; 40(1):164-74. PubMed ID: 9008612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of bovine cartilage proteoglycan in vitro is enhanced by inhibition of nitric oxide synthase.
    Hanglow AC; Rowan K; Lusch L; Coffey JW
    Inflamm Res; 1995 Aug; 44 Suppl 2():S151-2. PubMed ID: 8548373
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of a matrix metalloproteinase inhibitor, CGS 27023A, protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits.
    O'Byrne EM; Parker DT; Roberts ED; Goldberg RL; MacPherson LJ; Blancuzzi V; Wilson D; Singh HN; Ludewig R; Ganu VS
    Inflamm Res; 1995 Aug; 44 Suppl 2():S117-8. PubMed ID: 8548356
    [No Abstract]   [Full Text] [Related]  

  • 13. Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: matrix metalloproteinases-1 and -13 are involved in cartilage collagen breakdown.
    Shingleton WD; Ellis AJ; Rowan AD; Cawston TE
    J Cell Biochem; 2000 Sep; 79(4):519-31. PubMed ID: 10996843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism.
    Sztrolovics R; White RJ; Poole AR; Mort JS; Roughley PJ
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):571-7. PubMed ID: 10215595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism resistant isothiazolone inhibitors of cartilage breakdown.
    Wright SW; Petraitis JJ; Batt DG; Corbett RL; Di Meo SV; Freimark B; Giannaras JV; Orwat MJ; Pinto DJ; Pratta MA
    Bioorg Med Chem; 1995 Mar; 3(3):227-34. PubMed ID: 7606384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid and interleukin-1 together promote the release of collagen fragments from bovine nasal cartilage in culture.
    Cawston TE; Ellis AJ
    Ann N Y Acad Sci; 1996 Jun; 785():219-23. PubMed ID: 8702134
    [No Abstract]   [Full Text] [Related]  

  • 17. Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures.
    Price JS; Wang-Weigand S; Bohne R; Kozaci LD; Hollander AP
    Arthritis Rheum; 1999 Jan; 42(1):137-47. PubMed ID: 9920024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cartilage degradation and changes in physical properties induced by IL-1beta and retinoic acid using matrix metalloproteinase inhibitors.
    Bonassar LJ; Sandy JD; Lark MW; Plaas AH; Frank EH; Grodzinsky AJ
    Arch Biochem Biophys; 1997 Aug; 344(2):404-12. PubMed ID: 9264555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture.
    Arner EC; Pratta MA
    Arthritis Rheum; 1989 Mar; 32(3):288-97. PubMed ID: 2784682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteoglycan- and collagen-degrading enzymes from human interleukin 1-stimulated chondrocytes from several species: proteoglycanase and collagenase inhibitors as potentially new disease-modifying antiarthritic agents.
    DiPasquale G; Caccese R; Pasternak R; Conaty J; Hubbs S; Perry K
    Proc Soc Exp Biol Med; 1986 Nov; 183(2):262-7. PubMed ID: 3020566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.